Merck Lowers 2025 Profit Forecast as Tariffs and Licensing Costs Weigh

Despite beating Q1 earnings expectations, Merck adjusted its annual EPS guidance downward due to $200 million in tariff costs and a one-time charge tied to a licensing deal.